NCT01284621View on ClinicalTrials.gov

Relative Bioavailability of Empagliflozin (BI 10773) and Ramipril Administered Together Compared to Empagliflozin (BI 10773) and Ramipril Alone in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

March 31, 2011

Conditions
Healthy
Interventions
DRUG

BI 10773

medium dose, oral administration

DRUG

Ramipril

Medium dose oral administration on day 2-5

DRUG

BI 10773

medium dose oral administration

DRUG

Ramipril

Low dose oral administration on day 1

DRUG

Ramipril

Low dose oral administration on day 1

DRUG

Ramipril

Medium dose oral administration on day 2-5

Trial Locations (1)

Unknown

1245.45.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY